NASDAQ · Biotechnology

HUMA (HUMA) Stock

$0.66 -1.79% NASDAQ: HUMA Healthcare

Valuation

MetricValue
Price$0.66
Market Cap$110.81M
P/E Ratio-4.19
P/B Ratio20.96
P/S Ratio90.83
EPS (TTM)$-0.26
52-Week High$2.84
52-Week Low$0.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-409.47%
ROA-51.48%
ROCE-3566.67%
Gross Margin-7.49%
Operating Margin-56.49%
Net Margin-48.41%
Debt/Equity5.67
Current Ratio3.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$2.0M$0$0$2.0M
Operating Profit$-81.0M$-85.0M$-100.0M$-114.0M$-107.0M
Net Profit$-26.0M$-12.0M$-111.0M$-149.0M$-41.0M
EPS$-0.66$-0.12$-1.07$-1.26$-0.26
Op Margin-6429.8%-5404.4%——-5271.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$287.0M$204.0M$128.0M$138.0M$116.0M
Total Liabilities$164.0M$87.0M$115.0M$191.0M$113.0M
Cash$218.0M$150.0M$80.0M$45.0M$50.0M
Borrowings$51.0M$50.0M$57.0M$17.0M$65.0M

Latest News

Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know Zacks · Jul 14, 2026 Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access GlobeNewswire · Jul 14, 2026 Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why Zacks · Jun 30, 2026 Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data Simply Wall St. · Jun 27, 2026 Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market Zacks · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-81.0M$-71.0M$-73.0M$-98.0M$-105.0M
Investing Cash Flow$-8.0M$4.0M$-2.0M$-3.0M$-2.0M
Financing Cash Flow$239.0M$1.0M$-2.0M$28.0M$-88.0M
Net Cash Flow$178.0M$-68.0M$-69.0M$14.0M$-44.0M
Free Cash Flow$-81.0M$-72.0M$-76.0M$-100.0M$-106.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-5.78
EV / EBITDA-2.40
FCF Yield-55.91%
Quick Ratio3.32
Interest Coverage-9.73
Return 1Y-71.38%
Return 3Y-76.67%
Return 5Y-92.95%

Ownership

Insiders Held7.51%
Institutions Held22.31%
Institutions Float Held24.12%
Institutional HolderSharesReport Date
Blackrock Inc.12,316,9552026-03-31
Vanguard Capital Management LLC7,158,1622026-03-31
Antipodes Partners Ltd.5,723,7502026-03-31
Great Point Partners LLC3,750,0002026-03-31
Geode Capital Management, LLC3,658,1082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHV $6.66 +2.94% -4.63 $683.71M 0.00%
ARCT $6.26 +0.64% -2.93 $177.93M 0.00%
AVIR $4.75 +1.06% -2.13 $380.13M 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%
IMRX $4.24 -2.75% -3.94 $153.92M 0.00%

About HUMA

HUMA is led by CEO Laura E. Niklason, employs 218 people, headquartered in US, publicly traded since 2020.

HUMA stock trades at $0.66 with a market capitalization of $110.81M. The stock is valued at a price-to-earnings (P/E) ratio of -4.19, price-to-book of 20.96, price-to-sales of 90.83. Over the past 52 weeks the stock has ranged between $0.55 and $2.84, and currently trades 76.8% below its 52-week high.

On profitability, HUMA generates a return on equity (ROE) of -409.47%, return on capital employed of -3566.67%, an operating margin of -56.49%, a net profit margin of -48.41%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides